Transfection Technologies Market Growth Opportunities and Segmentation Report

The global transfection technologies market is expected to display higher growth rate over the next seven years. Rapid surge in transfection technologies industry is credited to the rising number of applications in drug discovery, gene therapy and therapeutics applications. The growing market for recombinant protein boosts the development of transfection technologies; biopharmaceutical companies are looking for technologies in hard to transfect cells in order to maximize production and product efficiency. Globally, transfection technologies market is predicted to generate massive revenue over the next seven years, providing numerous opportunities for industry participants to invest in research and development of transfection technologies.

Growing adoption of transfection technologies for cell research, recombinant protein production, drug discovery, gene therapy and therapeutics, is anticipated to foster the market growth of transfection technologies over the forecast period. Rising demand for recombinant protein is estimated to fuel market demand for transfection technologies over the coming years. Several biopharmaceutical organizations are focusing on implementing hard-to-transfect cell method to maximize production and product efficiency. Development of hard-to-transfect cell method is considered as the key market trend associated with transfection technologies industry.

Transfection is considered as an analytical method that is used to understand the function of genes and genes products in the cells. Transfection technologies help to introduce foreign nucleic acids into cells to form genetically modified cell. The transfection technologies market is segregated based on the type of method used to implement transfection technologies such as cotransfection, electroporation, cationic lipid transfection and In Vivo transfection.

Get Sample Copy of this Report @

The transfection technologies industry is broadly categorized into three major segments based on the application type such as pharmaceutical and biotechnology companies, contract research organizations, and academic & research institutes. Pharmaceutical and biotechnology companies segment is growing rapidly in the transfection technologies market with substantial revenue generation in the last few years.

The transfection technologies industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in implementation of latest technologies in bio-pharmaceutical sector, surge in number of research & development activities and existence of well-established industrial infrastructure in the region. In European region, Germany, France, and United Kingdom are projected to witness steady growth.

Asia-Pacific region is estimated to hold a major market share in the transfection technologies with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with strong economic growth, rapid advancement in bio-pharmaceutical sector, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the transfection technologies market are Agilent Technologies, Inc., Bio-Rad Laboratories Group, Lonza Group Co., Promega Corp., QIAGEN Corp., and Thermo Fisher Scientific.

Browse Related Category Market Reports @

Matched content

Editor’s pick

Express Press Release Distribution